Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/06/2023 | 4.88% | Goldman Sachs | → $35 | Reinstates | → Neutral |
08/29/2023 | 25.86% | Morgan Stanley | $39 → $42 | Maintains | Equal-Weight |
08/23/2023 | 22.86% | Mizuho | $40 → $41 | Maintains | Buy |
08/22/2023 | 22.86% | Mizuho | $40 → $41 | Maintains | Buy |
07/18/2023 | 16.87% | Morgan Stanley | $39 → $39 | Reiterates | Equal-Weight → Equal-Weight |
07/17/2023 | 7.88% | CIBC | → $36 | Initiates Coverage On | → Neutral |
07/07/2023 | 19.87% | Mizuho | $39 → $40 | Maintains | Buy |
05/17/2023 | 16.87% | RBC Capital | → $39 | Reiterates | Outperform → Outperform |
05/16/2023 | 7.88% | Citigroup | → $36 | Upgrades | Neutral → Buy |
04/25/2023 | 16.87% | Morgan Stanley | $41 → $39 | Maintains | Equal-Weight |
04/21/2023 | 7.88% | Raymond James | $40 → $36 | Downgrades | Strong Buy → Outperform |
04/18/2023 | 4.88% | JP Morgan | $36 → $35 | Maintains | Overweight |
04/18/2023 | 4.88% | Barclays | $36 → $35 | Maintains | Equal-Weight |
04/14/2023 | 4.88% | Scotiabank | → $35 | Assumes | → Sector Perform |
03/28/2023 | -7.1% | Truist Securities | → $31 | Downgrades | Buy → Hold |
02/28/2023 | — | Argus Research | Downgrades | Buy → Hold | |
02/28/2023 | 19.87% | Raymond James | $42 → $40 | Maintains | Strong Buy |
02/27/2023 | 1.89% | Bernstein | $37 → $34 | Downgrades | Outperform → Market Perform |
02/22/2023 | 7.88% | Wells Fargo | $37 → $36 | Maintains | Equal-Weight |
01/18/2023 | 10.88% | Barclays | → $37 | Downgrades | Overweight → Equal-Weight |
01/09/2023 | 22.86% | Morgan Stanley | $38 → $41 | Maintains | Equal-Weight |
12/16/2022 | 10.88% | Wells Fargo | $39 → $37 | Downgrades | Overweight → Equal-Weight |
12/09/2022 | 7.88% | Citigroup | → $36 | Initiates Coverage On | → Neutral |
10/20/2022 | 13.87% | Morgan Stanley | $40 → $38 | Maintains | Equal-Weight |
10/19/2022 | 4.88% | Barclays | $39 → $35 | Maintains | Overweight |
09/08/2022 | -10.1% | Goldman Sachs | $35 → $30 | Downgrades | Neutral → Sell |
08/16/2022 | 16.87% | Barclays | $38 → $39 | Maintains | Overweight |
08/03/2022 | 19.87% | Mizuho | $39 → $40 | Maintains | Buy |
08/03/2022 | 19.87% | Wells Fargo | $39 → $40 | Maintains | Overweight |
08/03/2022 | 25.86% | Raymond James | $40 → $42 | Maintains | Strong Buy |
05/20/2022 | 16.87% | Wells Fargo | $40 → $39 | Maintains | Overweight |
05/05/2022 | 19.87% | Wells Fargo | $38 → $40 | Maintains | Overweight |
05/04/2022 | 16.87% | Mizuho | $35 → $39 | Maintains | Buy |
05/04/2022 | 16.87% | RBC Capital | $35 → $39 | Maintains | Outperform |
05/02/2022 | 10.88% | Truist Securities | → $37 | Assumes | → Buy |
04/28/2022 | 13.87% | Wells Fargo | $35 → $38 | Maintains | Overweight |
04/26/2022 | 19.87% | Morgan Stanley | $34 → $40 | Maintains | Equal-Weight |
04/20/2022 | 19.87% | Raymond James | $36 → $40 | Maintains | Strong Buy |
03/24/2022 | 4.88% | Wells Fargo | → $35 | Maintains | Overweight |
03/17/2022 | 4.88% | Mizuho | $33 → $35 | Maintains | Buy |
03/16/2022 | 7.88% | Credit Suisse | $34 → $36 | Maintains | Outperform |
03/01/2022 | 1.89% | Stifel | $31 → $34 | Maintains | Buy |
02/23/2022 | 4.88% | RBC Capital | $32 → $35 | Maintains | Outperform |
02/23/2022 | 1.89% | Barclays | $33 → $34 | Maintains | Overweight |
02/23/2022 | 7.88% | Raymond James | $34 → $36 | Maintains | Strong Buy |
02/15/2022 | -1.11% | Mizuho | $31 → $33 | Maintains | Buy |
01/18/2022 | 4.88% | B of A Securities | $34 → $35 | Maintains | Buy |
12/17/2021 | -19.09% | Citigroup | $28 → $27 | Downgrades | Buy → Neutral |
12/16/2021 | 1.89% | Wells Fargo | $31 → $34 | Maintains | Overweight |
11/11/2021 | -1.11% | Credit Suisse | $30 → $33 | Maintains | Outperform |
11/03/2021 | -4.11% | RBC Capital | $30 → $32 | Maintains | Outperform |
10/19/2021 | -13.1% | Wolfe Research | → $29 | Downgrades | Outperform → Peer Perform |
10/18/2021 | -1.11% | Raymond James | $30 → $33 | Maintains | Strong Buy |
10/08/2021 | -7.1% | Mizuho | $30 → $31 | Maintains | Buy |
08/04/2021 | -10.1% | Mizuho | $29 → $30 | Maintains | Buy |
07/21/2021 | -10.1% | Raymond James | $28 → $30 | Maintains | Strong Buy |
06/24/2021 | -13.1% | Wells Fargo | $28 → $29 | Maintains | Overweight |
05/19/2021 | -13.1% | RBC Capital | $28 → $29 | Maintains | Outperform |
05/18/2021 | -13.1% | Credit Suisse | $28 → $29 | Maintains | Outperform |
05/17/2021 | -10.1% | Argus Research | → $30 | Upgrades | Hold → Buy |
05/13/2021 | -16.09% | Wells Fargo | $27 → $28 | Maintains | Overweight |
05/05/2021 | -13.1% | Mizuho | $27 → $29 | Maintains | Buy |
03/22/2021 | -16.09% | Morgan Stanley | $26 → $28 | Maintains | Equal-Weight |
03/04/2021 | — | ScotiaBank | Upgrades | Sector Perform → Sector Outperform | |
02/24/2021 | -19.09% | Mizuho | $26 → $27 | Maintains | Buy |
02/24/2021 | -25.08% | TD Securities | $24 → $25 | Maintains | Buy |
01/20/2021 | -22.09% | Mizuho | $24 → $26 | Maintains | Buy |
01/14/2021 | -25.08% | Raymond James | $24 → $25 | Maintains | Strong Buy |
12/17/2020 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
12/11/2020 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
12/03/2020 | -22.09% | SMBC Nikko | → $26 | Initiates Coverage On | → Outperform |
10/15/2020 | -37.07% | Goldman Sachs | → $21 | Downgrades | Buy → Neutral |
08/13/2020 | -34.07% | Credit Suisse | $20 → $22 | Maintains | Neutral |
08/06/2020 | -22.09% | Citigroup | $24 → $26 | Maintains | Buy |
08/05/2020 | -28.08% | TD Securities | $21 → $24 | Maintains | Buy |
07/21/2020 | -28.08% | Raymond James | $22 → $24 | Maintains | Strong Buy |
07/15/2020 | -25.08% | Morgan Stanley | $21 → $25 | Upgrades | Equal-Weight → Overweight |
06/01/2020 | -37.07% | Morgan Stanley | $19 → $21 | Maintains | Equal-Weight |
05/26/2020 | -31.08% | Mizuho | $20 → $23 | Maintains | Buy |
05/12/2020 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
04/30/2020 | -43.06% | Morgan Stanley | $17 → $19 | Maintains | Equal-Weight |
04/27/2020 | — | Wells Fargo | Upgrades | Equal-Weight → Overweight | |
04/22/2020 | -49.06% | Morgan Stanley | $14 → $17 | Maintains | Equal-Weight |
04/21/2020 | -31.08% | Goldman Sachs | $19 → $23 | Upgrades | Neutral → Buy |
04/16/2020 | -34.07% | Raymond James | $21 → $22 | Maintains | Strong Buy |
04/14/2020 | -43.06% | Wells Fargo | $20 → $19 | Maintains | Equal-Weight |
03/24/2020 | -52.05% | Barclays | → $16 | Upgrades | Equal-Weight → Overweight |
03/17/2020 | -25.08% | Stifel | $30 → $25 | Maintains | Buy |
03/16/2020 | -58.05% | Morgan Stanley | $25 → $14 | Maintains | Equal-Weight |
03/12/2020 | -37.07% | Bernstein | $25 → $21 | Upgrades | Market Perform → Outperform |
02/24/2020 | -28.08% | Wells Fargo | → $24 | Downgrades | Overweight → Equal-Weight |
02/19/2020 | -19.09% | Mizuho | $29 → $27 | Maintains | Buy |
01/14/2020 | -22.09% | Barclays | → $26 | Downgrades | Overweight → Equal-Weight |
01/06/2020 | -25.08% | Morgan Stanley | → $25 | Initiates Coverage On | → Equal-Weight |
12/13/2019 | — | SunTrust Robinson Humphrey | Initiates Coverage On | → Buy | |
12/06/2019 | -16.09% | TD Securities | $29 → $28 | Maintains | Buy |
12/03/2019 | -22.09% | Citigroup | $27 → $26 | Maintains | Buy |
11/25/2019 | -13.1% | UBS | $30 → $29 | Maintains | Buy |
11/04/2019 | -10.1% | UBS | $33 → $30 | Maintains | Buy |
10/23/2019 | -4.11% | Raymond James | $33 → $32 | Maintains | Strong Buy |
10/02/2019 | — | TD Securities | Initiates Coverage On | → Buy | |
09/03/2019 | -16.09% | Scotiabank | → $28 | Initiates Coverage On | → Sector Perform |
08/29/2019 | -4.11% | JP Morgan | $34 → $32 | Maintains | Overweight |
08/08/2019 | -10.1% | Credit Suisse | $33 → $30 | Maintains | Outperform |
08/08/2019 | — | Argus Research | Downgrades | Buy → Hold | |
08/06/2019 | -19.09% | Citigroup | $31 → $27 | Maintains | Buy |
08/05/2019 | — | Bernstein | Downgrades | Outperform → Market Perform | |
08/02/2019 | -10.1% | Stifel | $31 → $30 | Maintains | Buy |
06/26/2019 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
01/16/2019 | -7.1% | Barclays | → $31 | Upgrades | Equal-Weight → Overweight |
11/29/2018 | -4.11% | Mizuho | → $32 | Initiates Coverage On | → Buy |
11/02/2018 | -1.11% | B of A Securities | $38 → $33 | Maintains | Buy |
10/11/2018 | 4.88% | Credit Suisse | → $35 | Initiates Coverage On | → Outperform |
10/09/2018 | -22.09% | Goldman Sachs | → $26 | Initiates Coverage On | → Neutral |
What is the target price for Williams Companies (WMB)?
The latest price target for Williams Companies (NYSE: WMB) was reported by Goldman Sachs on October 6, 2023. The analyst firm set a price target for $35.00 expecting WMB to rise to within 12 months (a possible 4.88% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Williams Companies (WMB)?
The latest analyst rating for Williams Companies (NYSE: WMB) was provided by Goldman Sachs, and Williams Companies their neutral rating.
When is the next analyst rating going to be posted or updated for Williams Companies (WMB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Williams Companies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Williams Companies was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.
Is the Analyst Rating Williams Companies (WMB) correct?
While ratings are subjective and will change, the latest Williams Companies (WMB) rating was a with a price target of $0.00 to $35.00. The current price Williams Companies (WMB) is trading at is $33.37, which is within the analyst's predicted range.